Imaging of Retinoblastoma
Journal Title: GUJARAT CANCER SOCIETY RESEARCH JOURNAL - Year 2013, Vol 15, Issue 1
Abstract
Even after multiple awareness programmes, retinoblastoma still presents late in developing country like India where major crowd is still uneducated. Most of the patients present at advanced stage when eye / vision preserving treatment has no role and enucleation becomes essential. In this pictorial study we have tried to show various features of retinoblastoma on imaging modalities with its complication and its differential diagnosis. We have also discussed role of imaging in post treatment patients. Imaging features of retinoblastoma may help doctors to diagnose retinoblastoma earlier thus help the patient to opt for eye/vision preservating treatment options.
Authors and Affiliations
Himanshu Soni, Hitesh Rajpura, Jenny Gandhi, Vipashyana Jadav, Hiral Chaudhary
Keywords
Related Articles
- EP ID EP213163
- DOI -
- Views 52
- Downloads 0
Methotrexate Induced Hypersensitivity Pneumonitis in a Patient with T cell Lymphoblastic Lymphoma: A Case Report and Review of Literature
This case report describes presentation and management of methotrexate induced hypersensitivity pneumonitis. The patient, 17 year old male, was suffering from pre-T cell Lymphoblastic Lymphoma and was on maintenance ther...
Presentations at the Clinical Meetings
Presentations at the Clinical Meetings
Bleomycin Induced Pneumonitis: A Case Report and Review of Literature
This case report describes presentation and management of Bleomycin induced Pneumonitis. A 60 year old male patient, who was taking chemotherapy including bleomycin for treatment of Hodgkin’s Lymphoma, presented with com...
Extracorporeal Irradiation in Management of Primary Bone Tumors- An Institutional Experience
Primary bone tumor, which has made limb salvage possible. It consists of en-bloc removal of the tumor bearing bone segment, removal of the tumor from the bone, irradiation and reimplantation of the Extracorporeal Irradia...
Effectiveness of Low Dose Rasburicase in Prevention and Treatment of Adult Tumour Lysis Syndrome: A Case Series Study
Rasburicase, a recombinant urate oxidase product, is safe and effective in lowering serum uric acid. A schedule of rasburicase at a dose of 0.15-0.2 mg/kg given once daily intravenously for 5-7 days has been recommended...